Eldon C. Mayer's Insider Trades & SAST Disclosures
Eldon C. Mayer's most recent trade in Eiger BioPharmaceuticals Inc was a trade of 2,520 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on March 17, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eldon C. Mayer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 17 Mar 2023 | 2,520 | 57,948 (0%) | 0% | 1.1 | 2,696 | Common Stock |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 17 Mar 2023 | 1,875 | 56,073 (0%) | 0% | 1.1 | 2,008 | Common Stock |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 98,000 | 98,000 | - | - | Stock Option (Right to Buy) | |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 31,500 | 31,500 | - | - | Stock Option (Right to Buy) | |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 14 Mar 2022 | 1,657 | 60,468 (0%) | 0% | 5.6 | 9,275 | Common Stock |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 07 Jan 2022 | 1,560 | 46,125 (0%) | 0% | 5.0 | 7,722 | Common Stock |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 71,250 | 71,250 | - | - | Stock Option (Right to Buy) | |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 11,875 | 47,685 (0%) | 0% | 0 | Common Stock | |
| Eiger BioPharmaceuticals Inc | Eldon C. Mayer | Ex VP & Chief Commerc. Officer | Sale of securities on an exchange or to another person at price $ 11.68 per share. | 08 Jan 2021 | 1,690 | 35,810 (0%) | 0% | 11.7 | 19,739 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges